We use cookies to improve your experience

    We use necessary, analytics, and marketing cookies. You can customise your preferences or accept all. Cookie Policy

    Pharmaceutical & healthcare project management software

    Program control for pharmaand healthcare organizations

    In pharma and healthcare, a program that loses control doesn't just slip a deadline - it delays a drug to market, exposes an organization to regulatory risk, or affects the quality of patient care.

    Cerri Project provides the structural framework pharmaceutical and healthcare organizations use to govern development pipelines, healthcare delivery projects, and regulatory programs from intake through launch.

    Cerri Project is project management software for pharmaceutical companies and healthcare organizations that need governance, regulatory readiness, and audit-ready records - not just task tracking.

    • Govern drug development pipelines with structured gate criteria and regulatory readiness milestones
    • Manage healthcare IT, infrastructure, and quality improvement projects through a single governed intake
    • Maintain audit-ready decision records across scientific, clinical, regulatory, and operational teams

    Trusted by leading pharmaceutical and healthcare organizations

    AlcamiG&W LaboratoriesINMEGMcGill University Health CentreMcCullough-Hyde Memorial HospitalMedi-GlobeNuvance HealthPulsyAlcamiG&W LaboratoriesINMEGMcGill University Health CentreMcCullough-Hyde Memorial HospitalMedi-GlobeNuvance HealthPulsyAlcamiG&W LaboratoriesINMEGMcGill University Health CentreMcCullough-Hyde Memorial HospitalMedi-GlobeNuvance HealthPulsy

    Where pharmaceutical and healthcare project management loses control

    Pharmaceutical and healthcare organizations face different operational pressures - but the same underlying governance failures. If several of these feel familiar, program risk is already structural.

    Pharma & life sciences

    • Drug development programs progress through phases without structured gate criteria - decisions rely on informal consensus rather than defined evidence
    • Portfolio prioritization across the research pipeline is driven by advocacy rather than capacity and strategic value
    • Resource conflicts across discovery, development, regulatory, and clinical teams surface too late to avoid schedule impact
    • Regulatory submission readiness is assessed near the deadline - not tracked as a structured milestone throughout the program
    • Changes to development plans occur without impact assessment across the full program record
    • Portfolio visibility across concurrent development programs requires manual consolidation
    • Investment decisions on programs are made without clear visibility of development capacity or pipeline risk

    Healthcare organizations

    • IT, infrastructure, and service projects run in parallel with no consolidated portfolio view
    • Specialist clinical and IT staff are committed across projects with no cross-program resource visibility
    • Compliance and regulatory requirements are tracked separately from project delivery
    • Budget exposure grows across concurrent healthcare projects without structured tracking
    • Quality improvement and lean initiatives compete with operational projects for the same resources
    • Progress reporting to leadership and boards is assembled manually, not drawn from live data
    • Project coordination relies on spreadsheets and email rather than structured governance

    None of these are unusual in complex pharma or healthcare environments.

    What structured pharmaceutical and healthcare project management requires

    In healthcare and pharma environments, program control must operate across the full lifecycle - from pipeline prioritization and drug development through to operational delivery and quality management.

    Structure alone is not enough. Control must be measurable, enforceable, and traceable.

    Lifecycle governance and gate validation

    • Defined program phases with controlled transitions
    • Measurable criteria before progression
    • For drug development programs, no advancement without formal evidence of scientific, regulatory, and commercial readiness

    Pipeline prioritization and portfolio visibility

    • Portfolio-level visibility across research, development, and operational programs
    • Prioritization decisions driven by strategic value, available capacity, and investment exposure - not by internal advocacy or urgency alone

    Cross-functional capacity validation

    • Availability of scientific, clinical, regulatory, and operational expertise confirmed before program commitment
    • Cross-program visibility prevents structural overload across critical specialist roles

    Regulatory readiness tracking

    • Submission readiness governed as a structured program milestone - not a last-minute assessment
    • Compliance requirements tracked alongside program delivery throughout the lifecycle, not in a separate system consulted only at deadline

    Budget and investment control

    • Capital and program investment validated against maturity and pipeline priority
    • Budget vs forecast vs actual visibility across the portfolio
    • Early identification of cost exposure before it affects launch timelines or board decisions

    Auditable decision governance

    • Formally recorded decisions and approvals
    • Traceable changes to development plans, assumptions, and regulatory documentation
    • Version-controlled records ready for internal audit, regulatory inspection, or quality review at any point

    When regulatory review or internal audit requires evidence, the data is already available within the system - not assembled before the inspection.

    How Cerri Project works

    How pharmaceutical and healthcare project management actually works

    Cerri Project structures how programs enter review, how lifecycle gates are validated, how resources are committed, and how regulatory readiness is managed - from early research or project intake through delivery, launch, and post-market. This is what pharmaceutical project management software and healthcare project management software look like in practice - same governance backbone, different program types.

    01

    Structured program intake

    Every initiative - drug development program, clinical study, healthcare IT project, or quality improvement - enters with defined scope, resource requirements, and financial assumptions before review begins.

    02

    Lifecycle governance and gate validation

    Program phases and gate criteria are configured per program type. For drug development, governance criteria align with scientific and regulatory readiness. For healthcare projects, approval workflows reflect institutional and compliance requirements.

    03

    Cross-functional capacity confirmation

    Scientific, clinical, regulatory, and operational resource availability is validated before commitments are made - preventing the structural overload that delays development timelines and healthcare project delivery.

    04

    Regulatory readiness and compliance checkpoints

    Submission readiness and compliance requirements are governed through structured checkpoints - alongside budget and investment validation at defined program stages.

    05

    Live portfolio and program oversight

    Leadership sees consolidated portfolio status, cost exposure, resource pressure, and regulatory risk in real time. When governance reviews require structured evidence, the data is already in the system.

    See how it works in your environment

    Built for this environment

    Two distinct environments. One governance framework.

    Pharmaceutical project management for drug development and pipeline governance

    Pharmaceutical and life sciences organizations manage programs that extend from discovery and preclinical research through clinical development, regulatory submission, and commercial launch - requiring close coordination between scientific, regulatory, clinical, and commercial teams at every stage.

    • Pipeline prioritization across research and development programs aligned to strategic and commercial value
    • Stage-Gate governance configured to drug development phases and regulatory requirements
    • Resource allocation across therapeutic areas and concurrent development programs
    • Regulatory submission readiness tracked as a structured milestone throughout the program lifecycle

    Healthcare organizations - IT, infrastructure, and operational healthcare project management

    Hospitals, health networks, and healthcare providers manage complex portfolios of IT systems (PACS, EMR, ERP), infrastructure, regulatory compliance, and quality improvement programs - with limited specialist resources shared across competing demands. This is healthcare project management software built for the realities of hospital and health network operations.

    • Demand from clinical, IT, and administrative teams managed through structured intake
    • Resource capacity confirmed before healthcare project commitments are made
    • Continuous improvement and lean initiatives tracked alongside operational programs
    • Budget and CapEx visibility across the full healthcare project portfolio

    Deploy on your terms

    Pharma and healthcare organizations handle sensitive clinical data, regulatory documentation, patient records, and proprietary development data under strict governance obligations.

    • On-premise, private cloud, or hybrid deployment keeps your data within your own infrastructure and jurisdiction
    • Aligned with enterprise IT security policies and regulatory compliance frameworks
    • Full data sovereignty for organizations operating under strict pharmaceutical and healthcare regulation
    "From our perspective after looking at many similar products, Cerri Project seemed to have the best integrated document management and workflow solution in this price range while supporting the majority of functionality that we need. We felt that Cerri Project had the best blend of dashboard and reporting and hit the most functionality requirements that we had."
    M. Jason Hargrove
    Vice President of Administration
    Goold Health Systems

    Pharmaceutical and healthcare project management in operation

    Pharmaceutical project management and healthcare project management involve fundamentally different program types - but both require the same underlying governance: structured intake, confirmed capacity, controlled gate progression, and auditable decisions.

    Drug development programs progress through structured gates aligned to scientific and regulatory readiness - no advancement without formal evidence of criteria met.

    Healthcare projects - IT, infrastructure, compliance, quality improvement - enter through a single governed intake and are tracked against budget and resource in real time.

    Cross-functional capacity is confirmed before commitments are made across both development and operational teams.

    Audit trails, decision records, and version-controlled documentation are current and accessible - not assembled for the inspection.

    Program pipeline
    5 programs · 2 types
    Discovery / Intake
    Development / Build
    Validation / Test
    Regulatory / Review
    Launch / Go-live
    Oncology research program
    Pharma
    Gate 3 of 5 · Validation in progress
    Formulation development
    Pharma
    Gate 3 of 5 · Regulatory evidence gap - at risk
    EMR system rollout
    Healthcare
    Gate 4 of 5 · Compliance review underway
    Early-stage pipeline program
    Pharma
    Gate 2 of 5 · Development on track
    Quality improvement initiative
    Healthcare
    Gate 5 of 5 · Go-live preparation
    1 program at risk Audit trail active Cross-functional gates

    Ready to strengthen pharma and healthcare program governance?

    See how Cerri Project's pharmaceutical and healthcare project management software helps organizations manage complex development and operational programs from intake through delivery, compliance, and launch.

    Pharmaceutical and healthcare project management - frequently asked questions